Author:
Morgan Caroline Claire,Huyck Susan,Jenkins Martin,Chen Li,Bedding Alun,Coffey Christopher S.,Gaydos Brenda,Wathen J. Kyle
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
Reference14 articles.
1. Quinlan J, Gaydos B, Maca J, Krams M. Barriers and opportunities for implementation of adaptive designs in pharmaceutical product development. Clin Trials. 2010;7:167–173.
2. Gallo P, Chuang-Stein C, Dragalin V, Gaydos B, Krams M, Pinheiro J. Adaptive designs in clinical drug development: an executive summary of the PhRMA working group. J Biopharm Stat. 2006;16:275–283.
3. Food and Drug Administration. Guidance for Industry: Adaptive Design Clinical Trials for Drugs and Biologics. Washington, DC: US Department of Health and Human Services; 2010.
4. Wang SJ, Hung HMJ, O’Neill RT. Paradigms for adaptive statistical information designs: practical experiences and strategies. Stat Med. 2012;31:3011–3023.
5. Kitazawa Y; KP2035 Study Group. Phase III double-blind study of latanoprost/timolol combination (KP2035) in patients with primary open-angle glaucoma or ocular hypertension [in Japanese]. Jpn J Clin Ophthalmol. 2009;63:807–815.
Cited by
45 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献